Broadcaster Adrian Chiles and former footballer and blood cancer survivor Geoff Thomas joined patients, nurses, clinicians, fundraisers and major local businessmen in celebrating the 10th Anniversary of The Centre for Clinical Haematology (CCH) at the Queen Elizabeth Hospital, Birmingham.   Blood cancer charity Cure Leukaemia helps fund the CCH and has used this milestone as a springboard for its £3million capital fundraising campaign to help establish the Birmingham Institute of Haematology (BIH). This development of the CCH, which will double the capacity for treating blood cancer patients, running world first clinical trials and specialist research nurses required to administer these pioneering trials, was announced earlier this year and Cure Leukaemia is focusing its fundraising on the funding of this project.
 
President of the Birmingham Chamber of Commerce, Head of office at Pinsent Masons Birmingham and Cure Leukaemia Trustee Greg Lowson attended alongside CEO at Warwickshire County Cricket Club Neil Snowball, CEO of The Binding Site Charles de Rohan and MD of Elonex Outdoor Media Adam Stockton.
 
Blood cancer patients who have and continue to be treated at the CCH were also present to highlight the impact the Centre has had on so many lives since it was opened in May 2006.

Speaking at the event, Cure Leukaemia Patron Adrian Chiles said: “Cure Leukaemia has a superb business model that sees world first treatments administered to patients through clinical trials that can save lives in the process. This Centre also puts Birmingham firmly on the map; it is win, win, win all round. It is a pleasure to see how it has gone from strength to strength over the last decade.”

Broadcaster Adrian Chiles and former footballer and blood cancer survivor Geoff Thomas joined patients, nurses, clinicians, fundraisers and major local businessmen in celebrating the 10th Anniversary of The Centre for Clinical Haematology (CCH) at the Queen Elizabeth Hospital, Birmingham. To see exclusive photos from the day click HERE.
 
Blood cancer charity Cure Leukaemia helps fund the CCH and has used this milestone as a springboard for its £3million capital fundraising campaign to help establish the Birmingham Institute of Haematology (BIH). This development of the CCH, which will double the capacity for treating blood cancer patients, running world first clinical trials and specialist research nurses required to administer these pioneering trials, was announced earlier this year and Cure Leukaemia is focusing its fundraising on the funding of this project.
 
President of the Birmingham Chamber of Commerce, Head of office at Pinsent Masons Birmingham and Cure Leukaemia Trustee Greg Lowson attended alongside CEO at Warwickshire County Cricket Club Neil Snowball, CEO of The Binding Site Charles de Rohan and MD of Elonex Outdoor Media Adam Stockton.
 
Blood cancer patients who have and continue to be treated at the CCH were also present to highlight the impact the Centre has had on so many lives since it was opened in May 2006.

Speaking at the event, Cure Leukaemia Patron Adrian Chiles said:

“Cure Leukaemia has a superb business model that sees world first treatments administered to patients through clinical trials that can save lives in the process."
"This Centre also puts Birmingham firmly on the map; it is win, win, win all round. It is a pleasure to see how it has gone from strength to strength over the last decade.”